In this issue

Cell Cycle
Volume 11, Issue 10
May 15, 2012
View current issue
About the cover
Images of MCF-7 breast cancer cells overexpressing zinc transporter ZIP7 (green) localising to the endoplasmic reticulum. F-actin filaments stained red and...
Continue reading

It's Cell Cycle's 10th anniversary!

Launched in 2002 as a small bi-monthly journal,
Cell Cycle is now published bi-weekly, and we're still growing! Keep an eye out for Anniversary Editorials, Perspectives and Reports in forthcoming issues.

Most Popular Downloads

15 May 12
Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio
Anastasia Goloudina, Sharlyn Mazur, Ettore Appella, et al.
30 Nov 99
Preferential killing of p53-deficient cancer cells by reversine
Mohamed Jemaá, Lorenzo Galluzzi, Oliver Kepp, et al.
15 May 12
Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis
Tamara Ratovitski, Ekaterine Chighladze, Nicolas Arbez, et al.

Upcoming Meetings

4th ASM conference on Prokaryotic Cell Biology and Development
May 6th - 10th, 2012
Montreal, Canada

The Cell Cycle
May 15th - 19th, 2012
Cold Spring Harbor, New York

Origins of Tissue Stem Cells
May 24 - 25, 2012
Edinburgh, Scotland

Signaling by Adhesion Receptors
June 23 - 24, 2012
Waterville, Maine

Landes Highlights

Articles of interest recently published in our other journals

Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest. Coon et al. Cell Cycle 11(4); Feb 15, 2012.

EDD induces cell cycle arrest by increasing p53 levels. Veronique A.J. Smits. Cell Cycle 11(4); Feb 15, 2012.

 

Editor-in-Chief

M.V. Blagosklonny, M.D., Ph.D.
Roswell Park Cancer Institute
Buffalo, NY
Email the Managing Editor, Tara Barton.
Print ISSN: 1538-4101
Online ISSN: 1551-4005
IF: 2010 - 4.999
http://dx.doi.org/10.4161/cc
Abstracted/Indexed In:
Medline/PubMed, Science Citation Index Expanded (Web of Science), Scopus
In addition to the cell cycle and cell division, Cell Cycle covers all topics from man to virus, from DNA to RNA, from aging to development, from cell senescence to stem cells, from apoptosis to autophagy, from cancer to neurobiology, from molecular and theoretical biology to medicine and therapy.

Open Access in Cell Cycle

Cell Cycle offers a highly competitive open access fee for authors who wish for free access to and distribution of published articles. Authors retain copyright of their work by utilizing a Creative Commons attribution license. Open Access papers will be submitted to PubMed Central immediately upon final publication of each issue.

The cost to make an original research paper OA is $1000.00 USD.

For all other types of papers, the OA fee is $750.00 USD.

Find us on Facebook

Scooped?

If your lab's work was recently scooped by a paper in Cell, Nature or Science, please contact us for ultra-rapid peer-review and publication

Submit your paper to Cell Cycle

Cell Cycle utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.

There are 3 submission tracks to choose from:

  1. General Submission
  2. Select Submission Track
  3. Expedited Submission Track

Important Journal Links

Guidelines for Authors

Submit your manuscript online

Recommend Cell Cycle to your library

Select submission track: Cell Cycle will reconsider papers rejected by Science, Nature, Cell and others.

Cell Cycle recognizes that excellent papers may have been erroneously rejected by other journals. We will reconsider papers that have been rejected by Nature, Science, Nature Medicine, Nature Cell Biology, Cell, Cancer Cell, Cell Metabolism, Developmental Cell, NEJM, Lancet, Genes & Development and some other journals in the original format of those journals, thus saving the authors effort and time. The authors are encouraged to enclose the reviewers' and/or editorial comments from the above mentioned journals. This will certainly expedite the evaluation of the article and it is possible the article might be accepted based on its previous review. This will allow the urgent and competitive research to be published in a timely manner. You may submit your paper online. Following submission, please contact Yelena Boryskina, Assitant to the Editor-in-Chief, with the manuscript number and copies of the previous reviews. If you have questions, you may also contact Dr. Blagosklonny, the Editor-in-Chief, directly.
Advertisements